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Abstract
For the study of neuromodulation in Cancer borealis we have designed a microfluidic
device to separate and detect bioamine concentrations with a high temporal resolution.
Our goal is to use this device to measure the concentration of continuous bioamine
microdialysis samples directly from the pericardial cavity (the area surrounding the heart)
of Cancer borealis. The microfluidic device that we designed is made from
polydimethylsiloxane (PDMS) and exhibits an off-channel configuration of capillary
electrophoresis (CE) by incorporating micellar electrokinetic chromatography
(MEKC). CE is used to separate bioamines based on charge and size due to the applied
electrical potential. In the off-channel configuration, the potential is applied across the
separation channel and grounded by the palladium decoupler, which lies just before the
detector. Microchip CE is advantageous because it uses small amounts of analyte and
completes fast run times. We will use MEKC to separate dopamine and octopamine,
since they are structural isomers, by their difference in affinity to sodium dodecyl sulfate
(SDS) micelles. This results in different elution times for dopamine and octopamine.
We were able to drive the fluid in the correct direction. The creation of this device has
valuable implications, allowing for baseline concentrations of neuromodulators with the
Cancer borealis to be established. The effect of different stimuli on these crabs can then
be more accurately determined.
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Introduction

This project involves an interdepartmental effort between Dr. Ashley Kim’s lab
(bioengineering), Dr. Steven Suljak’s lab (chemistry), and Dr. John Birmingham’s lab
(physics) to study the effects of neuromodulators (chemical signals released by neurons
used to control the muscles of the organism) common to the crab Cancer borealis. The
goal is to study how different stimuli affect the neuromodulators of the crab. In order to
do this, it is necessary to create a device that has a high temporal resolution to measure an
accurate baseline.
Research done by an earlier group has focused on the concentrations of neuropeptides
and their correlation with physiological changes in Cancer borealis1. This background
provided us with a foundation for our proposed work, so that we could focus on the
analysis and measurement of these neuromodulators and more precisely quantify the
reactions of Cancer borealis in different environments. This particular crab species
serves as a simple model organism, allowing us to study the effects of these
neurohormones using only a small range of stimuli.
In order to obtain our sample data, we designed and manufactured a microfluidic device
that can detect the presence of very small concentrations of dopamine, norepinephrine,
octopamine, serotonin, tyramine, and gama-aminobutyric acid (GABA). We can then use
this device to obtain baseline concentrations from our target organisms, the crabs
themselves. Once we have a baseline, we can apply different stimuli to the crabs and
measure the real-time changes in concentrations of these neuromodulators from
hemolymph samples taken from the crabs using microdialysis.
In summary, we have made a microfluidic device to detect concentrations of six specific
neuromodulators that requires small volumes of sample, yields high sensitivity, achieves
fast detection, and is inexpensive.2,3
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2

System

2.1

System Overview

Below in Figure 2.1 is an illustration of the various components of our microfluidic
device and how they come together.

Figure 2.1: An overview of the microfluidic device project.

We used these enabling technologies and materials in the design, fabrication, and
experimentation of our device. The PDMS (polydimethylsiloxane) forms the device
itself, while the MEKC (micellar electrokinetic chromatography), capillary
electrophoresis, and the carbon paste electrode technologies allow us to separate and
detect our analytes. See Table 2.1 below for more details.
Our device uses the sampling technique microdialysis. Microdialysis is important to the
use of our device because it allows for continuous measurements, resulting in a higher
time resolution. While microdialysis can have slow sampling times, since it relies on
diffusion, the use of microchip capillary electrophoresis will decrease the sampling time.
Microdialysis will also allow us to filter out larger proteins and lipid chains in the
hemolymph sample. We will go into more detail on that later.1,4
2

Figure 2.2: The sampling technique microdialysis is placed in the pericardial sinus of the crab. The fluid
diffuses through a semi-permeable filter into a collection tube. In our case, the fluid will flow into our
device directly.

Table 2.1: Enabling technologies used in our design, along with brief descriptions and summaries of how
they will be used in our design.

Name

Description

Use

Capillary
electrophoresis
(CE)5,6

Electric field separation of
compounds with different
electrokinetic properties

Separate neuromodulators from a
Cancer borealis hemolymph sample
for detection

Amperometric
detection5,6

Detection of chemicals due
to changes in electrical
current

Detection of the neuromodulators
after they have been separated by
CE

Micellar
electrokinetic
chromatography
(MEKC)7,8

A technique to separate
compounds in CE with
similar electrokinetic
properties

Separation between dopamine and
octopamine (structural
isomers). Will use sodium dodecyl
sulfate micelles

3

2.2

Device Overview

Below is a simplified schematic of our device’s final design, as well as a picture of our
device as set up for experimentation.

Figure 2.3: Schematic of microfluidic device, features not drawn to scale. For approximate scale, the
entire device is about 5.5cm long.

Figure 2.4: Picture of our device in an experimental setup. The three microclips on the left and the
red/white alligator clips on the right are connected to platinum probes inserted into the wells. The
microclip on the right is connected to the palladium decoupler, and the green alligator clip is connected to
a copper lead wire for the carbon paste electrode.

We first fill our device with 1M NaOH for 20 minutes to precondition out device. Our
device is then filled with our 20mM TESa buffer before our sample is inserted into the
sample well. Our fluid flows through our device in two steps. In the load step, we set
our sample well to 600 V and the sample waste well to 0 V and pinching voltages of 570
V and 550 V for the buffer well and decoupler. The fluid flows down the voltage
a

(2-[1,3-dihydroxy-2-(hydroxymethyl)propan-2)yl]amino]ethanesulfonic acid). TES is a buffer with a pH
range from around 6.8 to 8.2

4

gradient from the sample well to the sample waste well. We then apply 600 V at the
buffer well and 0 V at the decoupler while having a pinching voltage of 454 V and 444 V
for the sample well and sample waste well. This results in the fluid flow from the buffer
well to the decoupler taking the separation volume that has our sample, down the
separation channel to flow over the carbon electrode.

2.3

Customer Needs and System-Level Requirements

The customer needs a higher temporal resolution than already existing technologies. Our
device uses a smaller sample volume along with having a higher sensitivity than other
existing technologies. As a result, we are able to satisfy the needs of the customer.

2.4

Benchmarking Results

Current mechanisms for studying the relationship of neuromodulators in Cancer borealis
and humans include capillary electrophoresis and liquid chromatography– mass
spectrometry. These technologies detect amine concentrations, but suffer from poor
sensitivity, poor time resolution, and/or high cost. The device we have designed provides
low cost fabrication, high time resolution, high sensitivity, and multi-analyte detection of
bioamines in Cancer borealis.

Table 2.2: Comparison of existing technologies and our device.

Approx.
Sensitivity

Sample
Size

Speed

Cost

Capillary Electrophoresis9

nanomolar (10-9)

around
100µL

Fast

Low

Liquid Chromatography-Mass
Spectroscopy10

micromolar (10-6)

around
1mL

Slow

Very
high

Microchip Capillary
Electrophoresis with Amperometry
(our device)

picomolar (10-12)

around
10-30nL

Very
fast

Very
low

Technology
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2.5

Functional Analysis

There are three sequential functions that our device was designed to perform:
Table 2.3: Description of three main functions of our microfluidic device. These functions happen
separately and sequentially in practice.

Function

Description

Sample
loading

The sample well is filled with the sample to be analyzed. Current flows
from the sample well to the sample waste well to electroosmotically fill
the separation volume with sample.

Analyte
separation

Current flows from the buffer well to the decoupler, which leads to
electroosmotic flow and electrophoretic separation of the analytes in
solution. Even though current stops at the decoupler, the fluid continues
moving.

Analyte
detection

Each volume of separated analyte flows past the carbon paste electrode,
where it is detected using amperometry.

2.5.1 Sample Loading
During the sample loading phase, our device is filled with buffer, and then sample is
injected into the sample well. We then apply an electric field across our device, and our
analyte is moved from the sample well to the sample waste well through a process called
electrophoresis. In the presence of an electric field, the charged ions present in the buffer
move towards the well set at the lower voltage. This causes bulk flow of the sample, and
the solution flows through the “T” segment in our device. Figure 2.4 shows a simple
schematic of this.

Figure 2.5: Our sample fluid flows from the sample well to the sample waste well as a result of the voltage
gradient that we create.

2.5.2 Analyte Separation
Once the “T” segment of the device has sample in it, we change the direction of the
electric field, as shown in Figure 2.5, setting the higher voltage at the buffer well, and
ground at our decoupler. Through electrophoresis, the sample that was present in the
6

“separation volume” area of the T, is moved down the channel toward the electrode.
Separation occurs due to the differing electrophoretic mobilities, or mobility of an analyte
in an electric field, of the analytes in solution. This variable is affected by the molecular
size and charge of each particle. Equations 1 and 2 are used to calculate electrophoretic
mobility (µp), using electrophoretic migration velocity (up), electric field strength (E),
length from inlet to detection point (L), migration time (tr), length of capillary (Lt), and
the voltage applied (V).

(1)

(2)

Figure 2.6: An electrode is connected to the buffer well and the decoupler so that we can create a voltage
gradient to cause the sample to flow down the separation channel.

2.5.3 Analyte Detection
Detection of our analytes is achieved by oxidizing the OH groups present on our
neuromodulators. This is done by holding our carbon paste electrode at a constant voltage
and measuring the current across it. When a molecule of analyte comes in contact with
our electrode, the oxygen-hydrogen bond is broken, causing the analyte to rearrange its
structure to accommodate the new carbon-oxygen double bond, which in turn releases a
free electron into the system. Since our analyte molecules have two OH groups, two
electrons are released per molecule. These electrons causes the current through our
electrode to increase slightly; the more analyte in contact with the electrode, the larger
the increase in current. As the sample moves past the electrode and there are no more OH
bonds to break to free up more electrons, the current dips back to the normal level,
giving us a spike. Since these neuromodulators move at different speeds, the current
spikes for the different analytes will take place at different times, helping us distinguish
how much of each neuromodulator is present in the sample.
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Figure 2.7: The fluid flows past the decoupler and carbon paste electrode into the separation waste
well. As the bioanalytes flow over the carbon paste electrode, a change in current is detected.

2.6

Technical Challenges

There were some technical challenges that we had to solve in order for our device to be
successful. The challenges and solutions are described in table 2.4.
Table 2.4: Technical challenges faced during the project. This may need to be turned back into
paragraphs if we need more detail in the explanations behind the decisions.

Challenge

Solution

Explanation

Separating
structural isomers

MEKC7,8

Sodium dodecyl sulfate could be used in
low concentrations to form micelles that
have a different binding affinity to each of
the structural isomers, meaning that one
of our analytes will move more slowly
down the channel.

Removing
hemolymph
matrix effects,
extra proteins,
and lipids

Use microdialysis with
a semi-permeable filter

As the fluid is extracted from the crab, the
fluid goes through a semi-permeable
membrane that has a specific molecular
weight cut-off to only allow the smaller
molecules that we want through, while the
larger proteins are filtered out.

Quantifying
differences in
signals

Conduct a large
quantity of runs to
develop current
standards for set
concentrations of
analytes.

Once we start getting repeatable data, we
can run solutions spiked with set
concentrations of analyte and measure the
signal current. When we have enough of
this data, we can have an idea of what
signal we can acquire for what
concentration.

Electrode fouling

Run a cleaning step

By running a voltage sweep that goes
8

Bubbles in the
device

before and after each
run.11,12

outside of the normal range for oxidation
and reduction of our analytes will serve to
clear our electrode of any fouling.

Ethanol runs

After each session with the device, we can
clear the separation channel with ethanol
to prevent the buildup of unoxidized
analyte, which will cause bubbles the next
time the channel is filled with buffer.

2.6.1 Separating Structural Isomers
The structural isomers (dopamine and octopamine in figure 2.7) will move down the
separation channel at the exact same speed, and since during detection, we can only see
free electrons, we are unable to tell the difference between them. In order to combat this,
we inject our samples with SDS (sodium dodecyl sulfate). This forms little spheres in the
solution (micelles) that the bioamines stick to. Dopamine has a higher affinity than
octopamine which causes the dopamine molecules to be slowed down more than the
octopamine molecules.

Figure 2.8: The structural isomers octopamine and dopamine

2.6.2 Hemolymph Filter
The hemolymph sample would not be able to be flowed through the device directly after
it was obtained from the crab because there are protein and lipid chains that will clog the
device. We will use microdialysis to solve this problem. The probe, which has a semipermeable membrane with a specified molecular weight cut-off, is placed within the
pericardial sinus. The smaller molecules diffuse through according to the concentration
gradient while the larger proteins and lipid chains are filtered out.

2.6.3 Signal Differences
Different concentrations of bioanalytes will give different current values. In order to
establish a current standard for different concentrations, multiple experiments for the
same concentrations are run until repeatable data is obtained. This is done for multiple
concentrations for different bioanalytes.
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2.6.4 Electrode Fouling
After one or two experiments our carbon paste electrode will not be as sensitive at
detecting the bioanalytes. As a result, we cleaned the electrode by running a voltage
sweep that goes outside of the normal ranges for the oxidation and reduction of the
analytes, returning the electrode to its original condition.

2.6.5 Bubbles in the Device
Bubbles in our device are detrimental to our success. One of the reasons that bubbles can
form is a result of a buildup of analyte around the decoupler and electrode. We flowed
ethanol through our device after each session of experiments to prevent this buildup from
occurring.

2.7

Team and Project Management

The following are the steps we are taking to ensure fair treatment among team members:
 We scheduled meeting times in the lab when we do our research.
 We scheduled meetings with our professor as a team where we expressed our
concerns and ideas about the project.
 Everyone is allowed to do everything and knows the procedure of how to do
anything within the project, allowing for better conceptual understanding and
problem solving within the group.
Communication is key when doing any sort of group project. We started by setting up a
group text message thread where we could post problems, updates, and talk about
meeting times, making sure that everyone was included and aware of what was going on
in the lab. Since our lab space and instruments were being shared by several groups, we
also decided to use a lab calendar to orchestrate when different groups could use the
microscope, Chi instrument, etc. to maximize lab time and space. All of our research was
also posted to a google document to allow multiple group members to edit and add to our
thesis and lab materials at the same time. We feel that the steps that we have taken to
ensure communication between team members are sufficient.
Refer to the Gantt chart in appendix A for more specifics on what each person
contributed to the project throughout the year.
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3

Subsystems

3.1

Wells

The wells, illustrated in figure 3.1, in our design were made out of approximately the last
5 mm of plastic pipette tips which we cut manually with a razor blade. The wells were
pushed down through holes punched in the PDMS. Although all of the wells were
constructed in the same way, their functions were different. Below is a figure showing
the locations of the wells and a table describing their functions.

Figure 3.1: Illustration showing the locations of the four wells in the device.
Table 3.1: Table describing functions of the four wells in the device.

Well

Function

Buffer well

Held extra buffer solution

Sample well

Held the sample to be analyzed

Sample waste
well

Collected excess sample after it had flowed from the sample well
during the load step

Separation
waste well

Collected waste sample after it had flowed down the separation
channel and across the detection electrode during the separation step

3.2

Separation Channel

The separation channel, shown in figure 3.2, is approximately 55mm long, 50µm deep,
and 50µm wide. This is the length of the channel past our sample well that will allow the
different analytes to separate based on electrophoretic mobility, or how quickly they
move in an electric field.

11

Figure 3.2: Illustration showing the location of the separation channel and our sample volume.

3.3

Decoupler

The decoupler, shown in Figure 3.3, was made of 0.025 mm diameter palladium
wire. Palladium was chosen for its excellent electrical conductivity. We use a decoupler
to electrically separate our grounding voltage from our carbon paste electrode. By placing
the decoupler in front of the electrode, we make sure that any effect that the electric field
used in electrophoresis could have on the electrode is mitigated. We did some tests to
measure current with the decoupler placed behind the electrode, and the results prove that
the decoupler placement is key. See figure in Appendix E.

Figure 3.3: Illustration showing the location of the decoupler.

3.4

Carbon Paste Electrode

The carbon paste electrode, shown in figure 3.4, was the detection mechanism for the
analytes once they had electroosmotically separated during their flow down the
separation channel. It was composed of graphite powder, multi-walled carbon nanotubes,
mineral oil, and PDMS. See appendix D for specific composition.1

12

Figure 3.4: Illustration showing the location of the carbon paste electrode.

3.5

Micelles

A small concentration of sodium dodecyl sulfate (SDS) can be added to our sample to
separate the two structural isomers that we are quantifying, octopamine and dopamine.
SDS forms micelles, or small spherical aggregates of around 60 monomers, in polar
solutions. Dopamine and octopamine have different polarities due to their chemical
structure, which causes them to have different binding affinities to the SDS micelles. The
analyte that has a stronger affinity to the micelles will move more slowly down the
separation channel, and so will show up as a separate peak in our amperometric detection
step at the electrode.7,8

3.6

Electrochemical Analyzer

The electrochemical analyzer was used as our detection monitoring system. The device
we used was the CHI800D model. While the electrochemical analyzer can be used for
multiple applications, we chose to use it for two main techniques: cyclic voltammetry and
amperometric detection. Cyclic voltammetry was used to determine that our electrode
was functional. The main technique used was amperometric detection. Amperometric
detection measures the current versus the time. As previously stated, when
neuromodulators flow past the electrode, there is a change in current that is detected, with
a different current peak for each neuromodulator. We are then able to determine the
concentrations of the different neuromodulators by measuring the current peaks. We
calculated the motility of each neuromodulator to determine which current peak belonged
to each neuromodulator. This technique is highly sensitive, which is what we were
looking for in our device.

3.7

High Voltage Sequencer

We use a high voltage sequencer in order to move our sample through the device. We
have four leads coming from the sequencer: one for the buffer well, sample well, sample
waste well, and one connected to the decoupler. We used platinum wire for the
electrodes that were in the wells while the lead for the decoupler was connected
directly. Voltage was applied to the device which in turn created electroosmotic
flow. The neuromodulators were separated based on their charge. Positive molecules
travel the fastest followed by neutrally charged molecules and negatively charged
13

molecules. Electroosmotic flow is preferred to pressure-driven flow because the
neuromodulators move in a “plug-like” profile while pressure driven flow moves the
neuromodulators in a parabola like profile. The electroosmotic flow will give our device
a higher sensitivity and better time resolution.

14

4

System Integration, Test

4.1

Fluorescent Test

Before we jumped straight into measuring bioanalytes through amperometric detection,
we wanted to make sure that the fluid would flow in the correct direction. To determine
this, we ran our experiment with fluorescein-dextran, figure 4.1, so that we could visually
see the fluid flow through the channel.

Figure 4.1: Fluorescent 40x magnification images of double T sample injector filled with fluoresceindextran by EOF. (1-3) Right leads to CE separation channel, top leads to sample waste reservoir, left leads
to buffer reservoir, and down leads to sample reservoir.
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4.2

Cyclic Voltammetry

We also wanted to determine that our carbon paste electrode would be able to detect the
bioanalytes through a change in current. We checked this first through cyclic
voltammetry. The results of that experiment our illustrated in figure 4.2.

Figure 4.2: CV conducted for our carbon paste electrode. Working electrode was the carbon paste,
counter and reference electrode were the Pd wire decoupler. The straight lines around 0 microamps show
when the solution only consisted of the buffer. When a drop of 1 mM dopamine was added to the solution,
the current was able to fluctuate between around 0.2 and -0.3 microamps.

16

4.3

Amperometric Detection

4.3.1 Pressure Driven Flow
We checked that our carbon paste electrode could also detect the bioanalytes as the fluid
flowed through the channel. This was done through amperometric detection using
pressure driven flow from a syringe at the buffer well. The results are shown in figure
4.3.

Figure 4.3: Amperometric detection of 1mM dopamine solution using electroosmotic flow for the load step,
and pressure driven flow for the separation step.
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4.3.2 Spiked Dopamine Runs
Now that we were able to confirm that our fluid was flowing in the correct direction and
that our carbon paste electrode could detect these bioanalytes, we experimented using
amperometric detection with electroosmotic flow. Figure 4.4 and figure 4.5 show our
experiments using a 1 mM spiked dopamine solution.

Figure 4.4: Amperometric detection of 1mM dopamine solution using electroosmotic flow for the load and
separation step. Note the wide sloping peak, and the uneven fall off in current after the analyte has passed.
Most likely caused by current continuing to leak from the separation well, causing uneven flow of analyte
down the channel.
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Figure 4.5: Amperometric detection of 1mM dopamine solution using electroosmotic flow for the load and
separation step. This steep peak shows the desired increase in current, but the other smaller spikes after the
large one are also from dopamine (the only analyte in the solution), and are most likely caused by a faulty
separation step.

4.3.3 Catechol Run
We also tried our experiments with catechol instead of dopamine and got similar results.

Figure 4.6: Amperometric detection of 1mM catechol solution using electroosmotic flow for the load and
separation step. The sharp increase in current shown is what we expect, however the slow fall off could
indicate a faulty separation step as well. Note how the catechol peak occurs around 22 seconds after the
separation step, while the dopamine runs took between 12 and 14 seconds. This is expected, because
catechol is neutral at this pH, and therefore has a lower electrophoretic mobility.

19

4.4

Platinum Node Test

In order to determine that our platinum nodes were all working the same, we ran some
current tests through our device to measure the currents that each platinum node was
giving off as well as receiving. Figure 4.7 illustrates the result of one of these tests. We
did the same experiment on all the platinum nodes and got similar results.

Figure 4.7: We had one electrode in the sample well (ch. E) and another electrode in the sample waste well
(ch. H). We applied 600 V to ch. E and 0 V at ch. H. We then reversed the voltages around 8 sec. We did
this test multiple times and swapped different platinum nodes for each test. Each test gave similar results.
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4.5

Known Resistor Voltage Test

When checking our voltage sequencer to see if it was giving off the correct current, we
connected our instrument to a known resistance of 30 MΩ. We ran multiple voltages
through the circuit and measured the currents that the voltage sequencer instrument
software gave us. We compared these to the theoretical values. The difference between
the two values versus the voltage is shown in figure 4.8.

Figure 4.8: We connected our high voltage sequencer to a known resistance of 30 MΩ and measured the
current at different voltages. We compared that to the current that we expected.
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5

Discussion

The first experiment that we ran with our device was to use fluorescent dye instead of our
crab sample to verify that our fluid was travelling in the correct direction. As shown in
figure 4.1, we did get the fluorescent dye to flow in the correct directions for the load step
and separation step. We then moved on to amperometric detection through
electroosmotic flow of a stock solution of 1 mM dopamine. Unfortunately, we were not
able to get very favorable results. We were able to get the load step to work almost every
time, but the separation step was inconsistent. There were a few experiments which gave
potential dopamine peaks, but there was either so much noise that we could not say with
certainty that the peaks were a result of the dopamine being detected at the electrode, or
the current would increase quickly and then decrease slowly, which was most likely a
result of dopamine leaking into the separation channel from the other channels.
We hypothesized that the potential problems with our device could be with the carbon
paste electrode, the platinum nodes, or the voltage sequencer. In order to determine that
the carbon paste electrode could detect bioanalytes we first performed cyclic
voltammetry (CV). Figure 4.2 shows that when dopamine was added to the solution
during CV, the stereotypical “anode” and “cathode” peaks were present, showing at
which current the dopamine molecules were getting oxidized and reduced respectively.
This tells us that our electrode is capable of holding detecting the current change when
these two phenomena occur.
We could then conclude that our carbon paste electrode was able to detect the
dopamine. We also wanted to verify that the carbon paste electrode could detect
dopamine as it was flowed over it. We tested this by doing a pressure driven flow
test. We conducted the load step as we normally would using electroosmotic flow, but
instead of using electroosmotic flow for the separation step, we used a syringe at the
buffer well to push the sample down the separation channel and past the carbon paste
electrode. Figure 4.3 shows the results of this test.
With the positive result we were able to conclude that carbon paste electrode was not the
problem. We then tested the platinum nodes to see if those could be the problem. To do
this we used sandpaper to rub off any residue that could be on the platinum wire and then
immersed them in ethanol. The load step was performed with each of the platinum wires
to determine if there was any difference between them. Figure 4.7 shows the current that
was detected for one of the tests, and the other test give similar results. This led us to
conclude that since all of the platinum nodes acted the same, they were not the
problem. The last component we tested was the voltage sequencer. A known resistor of
30 MΩ was connected to the voltage sequencer and the current was measured at different
voltages. Figure 4.8 shows that we determined a false positive current coming from the
voltage sequencer. The voltage sequencer is part of the problem, and we will continue to
test other components to determine if there are other problems.
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Some improvements that we will incorporate to our project in the future is first to try our
experiments with a different voltage sequencer to determine if that solves our
problems. If that does solve our problems, we will move forward with detecting
dopamine using amperometric detection and eventually use a hemolymph sample in our
device that separates multiple bioanalytes. If it does not solve all of the problems, we
will attempt to change the design of our device. There will be another group next year
that will continue this project, and we intend to leave them with the knowledge necessary
to address these issues.
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6

Cost Analysis

A large budget is not needed to make our device (refer to appendix C). In actual practice,
our device costs even less to make than what the budget illustrates because hundreds of
devices can be made using our budget. This accomplishes our goal of making an
inexpensive device. The only drawback is that in order to detect the neuromodulators
using our device, a high voltage sequencer and an instrument that uses amperometric
detection is needed. These two pieces of equipment can be very expensive with them
costing over $10,000 each. However, while it may be a large investment at the
beginning, we could amortize the cost of the equipment.
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7

Engineering Standards and Realistic Constraints

7.1

Ethics

Ethics is an important topic to look at when creating an invention. Our team is acting
ethically when it comes to our project because our project is for the purpose of making a
better world and there are no materials or resulting devices that cause harm to anyone.
The only ethical concern that people might have is that we use crabs for our experiment,
and there have been some studies that show that crabs could feel pain.
One big issue with animal testing is whether or not the animals are sentient. Sentience is
a difficult term to define, but it’s generally understood to mean that the organism can
distinguish itself from others. It is unknown as to when a nervous systems becomes
complex enough to be known as ‘self-aware’. Generally, most mammals and some birds
are considered sentient, but the invertebrate world is not generally considered to possess
this attribute. There have been some studies that allow for the possibility of cuttlefish and
octopi being sentient, but given our current knowledge, we don’t think that insects and
worms, or the crabs that we use for our samples, are self-aware. Whether or not the crabs
feel pain however, is another issue entirely.
According to a few studies (one most recently Dr. Elwood at the Queens University
Belfast in the UK), crabs exhibit a type of avoidance behavior that has been associated
with feeling pain.13 During Dr. Elwood’s study, crabs were given mild shocks when they
entered one type of shelter over another, and after repeated trials, the crabs were far more
likely to avoid the shelter types that had shocked them and would prefer to seek shelter
elsewhere. A similar test was done on mice, and the evidence gleaned from these
experiments supported the case that mice do feel pain, prompting many quality-of-life
changes to allowed testing procedures. While not being completely harmless, our
procedure is designed to be quick and effective, and gives the crabs time to get used to
the dialysis probe before starting to take samples. We also attempt to numb the crab by
placing them in cold water and ice for almost 20 minutes before performing our surgery.
We do have to poke a small hole through the shell in order to insert the probe however,
and this approach may cause trauma to the animal. If this procedure causes the crabs too
much pain, we might need to change the way that we get samples, or chose another
sample organism outright.
After we acquire enough data to establish what the baseline (normal state) concentrations
of these neuromodulators are, then large changes in certain hormones that we are testing
for might indicate that we are causing too much pain. Norepinephrine (NE) and dopamine
(DA) for example, are two of our analytes that we could use to determine our impact on
the crabs. Norepinephrine is a stress hormone that is responsible for the fight or flight
response, as well as increasing heart rate and blood pressure. Dopamine has many tasks,
but is the hormone that is most responsible for the sensation of pleasure. A steep increase
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in NE, or a precipitous drop in DA concentrations could indicate that we are causing too
much trauma to our subject.
If that is the case, we could attempt to further numb the crabs with general anesthesia
before inserting the probe into their shells. This would be more expensive (on account of
the need to purchase the drug), and would most likely ruin any data that we would
attempt to acquire over the next few days, as the anesthetic would take time to break
down inside the organism. If this doesn’t work, we could always just take the frozen
hemolymph samples from the physics department after they have already ‘sacrificed’ the
crabs for their neurobiology research. Unfortunately this method would severely limit any
post detection analysis that we could conduct because all of our data would be from dead
crabs, preventing us from seeing any changes in neuromodulator concentrations due to
altered environments.

7.2

Social

We have an ethical duty to our potential users to make the device safe to use. If we start
to take advantage of our user’s welfare then we have gone too far and need to rethink
what we are doing. There is always some sort of ethical responsibility that a company has
for using a product or service. Even though the customer is using it, there is still the
responsibility of the company to not sell them an unethical device. Now if the user starts
to change the manufactured settings, then it becomes primarily the user’s responsibility.
Our device does not have any unintended consequences. It detects concentrations of
different bioamines. If someone decided to change it and detect concentrations of
something else, we see no problem with that in itself.

7.3

Environmental

When creating an invention, it is important to consider if the device itself will be
environmentally friendly. Our device is created out of PDMS which, while nonbiodegradable, does not have any harmful effects towards organisms. In fact, it is in
some fast food products.

7.4

Health & Safety

There are two main risks pertaining to our project: shocking ourselves with the voltage
sequencer and accidentally sticking ourselves with a needle. In order to ensure safety
while using the voltage sequencer, we announce to everyone around that we are going to
turn on the sequencer so that everyone knows not to touch the leads. Also, we make sure
to only touch one lead at a time so as not to accidentally complete the circuit if the
sequencer happened to be on. With the needles we just make sure to never point them
towards anybody, and to constantly keep them covered when not in use. We also use low
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concentration sodium hydroxide to clean our device between runs, and 98% ethanol to
remove dust particles from our working surfaces. Other than those risks, there are not any
other concerns because aside from the sodium hydroxide, our materials are not bioactive.

7.5

Economic

When thinking about who the consumers of our product would be, we came to the
conclusion that it would most likely be people in the developing world. As a result, we
wanted to make our device affordable to that type of consumer. The materials that we
chose were a big factor because we did not want them to be really expensive. We chose
to use PDMS because it is affordable and has been known to be used for similar
applications. We also had to consider the other instruments that would need to be used in
addition to our device. Unfortunately, the voltage sequencer and electrochemical
analyzer are not very affordable, but that is a challenge for all microfluidic systems.

7.6

Aesthetics

Our design is more for the functionality than the aesthetics, but our device design (Figure
2.2) is a very simple and symmetrical device. It is small and does not require very much
skill to use. The look of the device is not the most attractive thing, but as we make
progress we can make a shell for the device so as to make it more appealing and look
simpler. But one thing that does make our device aesthetically pleasing is its simple,
straightforward design in performing a complex task: the detection of bioamines. The
approach we used is aesthetically impressive because it is an elegant and sensitive
solution to a problem traditionally solved with larger, more expensive technologies.
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8

Summary

We are involved in a joint project with the physics department and chemistry department
that is studying the effects of neuromodulators common to the crab Cancer borealis. We
aimed to create a device that had a temporal resolution, which in turn would provide an
accurate baseline of neuromodulators in the crab. Our finished device seeks to have fast
detection, be highly sensitive, require small sample volumes while maintaining
affordability. The use of PDMS, microchip capillary electrophoresis, carbon paste
electrode, and MEKC are all components that will help to achieve that goal. The new
accomplishments that we achieved this year were the following:





Established the PDMS-PDMS bonding procedure.
Created multiple channel and electrode master molds using photolithography
techniques, which was much cheaper than ordering them from Stanford.
Attained successful fluorescent dye test showing the flow of the fluid in the
correct direction.
Successful pressure driven flow test, showing that we can detect bioanalytes using
amperometric detection with small sample volumes.

These new accomplishments will help the next group who takes on this project to truly
focus on figuring out the amperometric detection with electroosmotic flow with our
device. Once that can be accomplished, more extensive tests will be feasible with
multiple bioanalytes and eventually hemolymph sample from the crab Cancer
borealis. This will allow for a baseline of neuromodulator levels to be established,
allowing researchers to see how different stimuli affect these neuromodulator
levels. Eventually, this device could potentially be used for similar tests in humans.
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Appendices

Appendix A: Gantt Chart
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Appendix B: Risks and Mitigations
Table B.1: Risks and Mitigations
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Appendix C: Budget
Table C.1: Budget
Amount
5 x 0.5 kg

Amount
$216.00

Item
PDMS Mix

Use
Forms Device

Palladium
decoupler (.05
mm)

Disrupts Applied
Potential

2m

$326.00

$271.00

Epoxy

Secures
wires/insulation

8 pack

$52.00

$0.00

Scalpel

Cuts device to size

2 pack

$20.00

$8.00

Tubing

Used during
testing

1m

$8.00

$0.00

Pipet tips

Used as the well

$16.00

$34.00

Weigh boats

Used to mix
chemicals

200 pack

$30.00

$0.00

Hole Punch

Forms well for
injection site

2

$30.00

$0.00

Masks

Design mold

3

$100.00

$95.00

Tape

Removing excess
carbon paste

12 rolls

$24.00

$0.00

Maintenance

$300.00

$0.00

Shipping

$50.00

$0.00

Stanford mold

Mold to make
devices

Cleanroom
wipes

No lint wipes to
wipe up liquid

Actual
$327.00

1

$301.00

300 pack

$16.00

TOTAL

$1,172
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$1,052

Appendix D: Fabrication Procedure14,15
Device fabrication takes place in several steps.

Mold Fabrication
Blue film mold. For our electrode side slab, we used a mold that we created ourselves. By
using the mask from Dr. Abbyad’s mold, we were able to print 50µm blue film onto a
glass slide, that we then developed using UV light using the following procedure:
1. Cover one side of a 3”x2” glass microscope slide with 50µm UV-sensitive blue
film, making sure that there are no bubbles present.
2. Fold a piece of regular printer paper in half and place the glass slide inside the
folded halves. Run the paper and slide through a heat laminator (speed 6 for our
laminator).
3. Carefully align the mold mask on top of the blue film and expose with UV light
for three seconds.
4. Develop in 1% potassium carbonate solution for about 5 minutes by submerging
the mold in the solution and then vigorously squirting the the surface of the mold
with a pipette. Pay close attention to the amount of undeveloped blue film on the
surface, and stop developing immediately once it has all been dissolved.
For the other side of our device, the channel side, we used a mold that we bought from
Stanford. The longer, thinner channel gave us much more trouble, and we would often
over or under develop our mold, and be forced to start over. By ordering a SU-8 mold
from Stanford, we added a little cost to our project, but removed a large source of error in
the fabrication of our device.

PDMS Curing
After our molds are created, we measure out silicon base and binder in a ratio of 10:1,
allowing for approximately 20g of PDMS per device we are trying to make. Before
pouring the uncured PDMS onto the mold, we make sure to vigorously mix the base and
binder together. Once the PDMS is poured onto the mold, we place the mold into a
vacuum desiccator to pull out the air bubbles that are dissolved in the uncured PDMS
before it hardens. After about an hour in the desiccator, we transfer the mold over to the
78º oven for 4 hours to completely cure it.

Device Prepping
After the PDMS has cured in the oven, we cut out the slabs from the extra PDMS and
pull them off of the mold. We then make the carbon paste electrode by taking a drop of
the uncured PDMS from the mixing bowl and an equal weight of mineral oil in a dish.
Graphite powder and MWCNT (multi-walled carbon nanotubes) are then added in a 10:1
ratio to equal the mass of the mineral oil and uncured PDMS together. This is then mixed
very well until it is of even consistency.
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Then we screen print our electrode slot with the carbon paste mixture, ensuring that only
the correct amount of paste is on our device by pulling excess layers off with strips of
Scotch tape.
Whenever our slabs are not in use, we cover the printed side with a layer of scotch tape to
prevent dust from getting caught in our channel.
After our electrode has been printed, we need to insert our palladium decoupler into the
decoupler slot. To accomplish this, we carefully cut into the decoupler slot along the edge
of the device with a razor blade, and then pull the wire into these slots and around the
back of the device, taping it off at both ends.

Bonding16
After the decoupler has been secured inside its slot, we bring the two unbonded slabs to
the plasma bonder. We punch 1mm holes through each of the wells to allow for
connections to the outside of the device once the pieces are bonded together. We then
remove the protective tape and place the slabs face up into the plasma bonder.
In order to secure a good vacuum and good plasma, we turn on both the pump and the
plasma cleaner at the same time, and then do not turn the actual plasma on until the
pressure inside the chamber is below 300 mtorr. When this threshold is passed, we turn
off the vacuum and turn the plasma on high, allowing a small inlet to form, increasing the
quality and volume of the plasma (displayed by a rosy pink color), which we maintain for
50 seconds. We then turn off the plasma and the plasma cleaner, and open the door after
the vacuum has been released.
The two sides of the device are firmly pressed together and then this process is repeated
to bond a glass slide to the back of the device, adding structural support.
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Appendix E. Current without Decoupler

Figure E.1: Amperometric detection step of purely buffer solution using a device without a decoupler. The
two step level currents are purely generated by the field present in the load step (the lower currents) and
the separation step (the higher currents). This shows the necessity of having a decoupler before the
electrode.
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Appendix F: Material Sources
Table F.1: List of the instruments and materials we used from other suppliers.

Item

Supplier

Item Number

Electrochemical Analyzer

CH Instruments

CHI800D

Voltage Sequencer

LabSmith

HVS448-6000D

Palladium (decoupler)

Goodfellow

PD005113

Pipette tips (wells)

Fisher Scientific

02-707-447

Photolithography mask

CAD/Art Services

N/A
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